V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10477319 | 10054516 | 1.74 | null | Palliative (P) | 2021-02-02 | 2021-02-13 | GemCarbo Days 1+8 | 02 | N | CARBOPLATIN + GEMCITABINE | 101533098 |
| 10477334 | 10054517 | 1.63 | 0 | null | 2018-02-26 | 2018-02-27 | CEMIPLIMAB | 01 | null | CEMIPLIMAB | 100421171 |
| 10477373 | 10054518 | 1.67 | 88.8 | null | 2021-07-26 | 2021-08-07 | Venetoclax | 02 | null | VENETOCLAX | 100163198 |
| 10477406 | 10054519 | 1.75 | null | null | 2022-01-31 | 2022-03-01 | CEMIPLIMAB | 02 | null | CEMIPLIMAB | 100486177 |
| 10477420 | 10054520 | 1.66 | 62.4 | Palliative (P) | 2016-12-10 | 2016-12-19 | FLUOROURACIL + OXALIPLATIN | 02 | N | FLUOROURACIL + OXALIPLATIN | 100828682 |
| 10477453 | 10054521 | 1.59 | 60.8 | Adjuvant (A) | 2019-07-28 | 2019-07-28 | FLUOROURACIL + IRINOTECAN | 02 | N | FLUOROURACIL + IRINOTECAN | 101485818 |
| 10477456 | 10054522 | 1.58 | 61 | Palliative (P) | 2021-03-15 | 2021-04-03 | CEMIPLIMAB | 02 | N | CEMIPLIMAB | 101226536 |
| 10477494 | 10054523 | 1.72 | null | null | 2021-09-14 | 2021-09-24 | BENDAMUSTINE + RITUXIMAB | 02 | null | BENDAMUSTINE + RITUXIMAB | 100376834 |
| 10477509 | 10054524 | 1.82 | 116.2 | null | 2020-08-02 | 2020-09-09 | Avelumab | null | null | FLUOROURACIL + IRINOTECAN | 100337938 |
| 10477711 | 10054525 | null | 68.3 | null | 2019-02-10 | 2019-03-01 | Irinotecan + Modified De Gramont | null | null | FLUOROURACIL + IRINOTECAN | 101433017 |
| 10477780 | 10054526 | 1.79 | 47 | Palliative (P) | 2018-01-30 | 2018-01-30 | RUXOLITINIB | 02 | N | FLUOROURACIL + IRINOTECAN | 101618022 |
| 10477816 | 10054527 | 1.9 | 63.7 | null | 2017-11-16 | 2017-11-29 | Avelumab | 02 | null | CARBOPLATIN + GEMCITABINE | 101517767 |
| 10477867 | 10054528 | 1.73 | 76 | null | 2018-01-24 | 2018-02-05 | Avelumab | 02 | null | DARATUMUMAB | 101346161 |
| 10477940 | 10054529 | 1.78 | 95.8 | null | 2017-05-03 | 2017-05-13 | Avelumab | 02 | null | FLUOROURACIL + OXALIPLATIN | 101656990 |
| 10477969 | 10054530 | 1.85 | 81.2 | null | 2017-09-21 | 2017-10-01 | Avelumab | 02 | null | AVELUMAB | 100782003 |
| 10477990 | 10054531 | 1.5 | 86.4 | Palliative (P) | 2017-10-05 | 2017-10-23 | Venetoclax | 02 | N | VENETOCLAX | 100880198 |
| 10477993 | 10054532 | 1.75 | 51.96 | 03 | 2020-06-01 | 2020-06-01 | CEMIPLIMAB | 02 | N | CEMIPLIMAB | 100319538 |
| 10477995 | 10054533 | null | 61.6 | null | 2022-01-10 | 2022-01-21 | Avelumab | 02 | null | FLUOROURACIL + OXALIPLATIN | 100905555 |
| 10478018 | 10054534 | 1.86 | 62.2 | Palliative (P) | 2020-03-08 | 2020-03-10 | Avelumab | 02 | N | CARBOPLATIN + GEMCITABINE | 101065849 |
| 10478028 | 10054535 | 1.75 | 65 | null | 2020-01-25 | 2020-02-14 | Avelumab | 02 | null | CEMIPLIMAB | 100334345 |
| 10478030 | 10054536 | null | 35 | null | 2020-05-07 | 2020-05-23 | Venetoclax | 02 | null | VENETOCLAX | 100773573 |
| 10478043 | 10054537 | 1.57 | 78.3 | null | 2019-06-07 | 2019-06-21 | FLUOROURACIL + OXALIPLATIN | 02 | null | FLUOROURACIL + OXALIPLATIN | 101700979 |
| 10478061 | 10054538 | 1.65 | 89 | Palliative (P) | 2019-07-29 | 2019-08-11 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101807256 |
| 10478099 | 10054539 | 1.67 | 61.2 | null | 2019-05-14 | 2019-06-06 | Avelumab | 02 | null | FLUOROURACIL + IRINOTECAN | 101248703 |
| 10478206 | 10054540 | 1.49 | 74.5 | Palliative (P) | 2022-02-18 | 2022-02-18 | Avelumab | 02 | N | FLUOROURACIL + IRINOTECAN | 101269681 |
| 10478223 | 10054541 | 1.5 | 100 | 03 | 2019-04-16 | 2019-04-30 | Avelumab | 02 | N | FLUOROURACIL + OXALIPLATIN | 100055196 |
| 10478241 | 10054542 | 1.77 | 79.8 | Palliative (P) | 2020-02-03 | 2020-02-16 | Bendamustine+Rituximab(Sub Courses) | 02 | N | TRASTUZUMAB | 100094916 |
| 10478244 | 10054543 | 0 | 65 | 03 | 2020-03-05 | 2020-03-14 | CEMIPLIMAB | 02 | N | CEMIPLIMAB | 101562540 |
| 10478268 | 10054544 | 1.82 | null | null | 2019-07-23 | 2019-08-13 | Avelumab | 02 | null | CARBOPLATIN + GEMCITABINE | 101682411 |
| 10478284 | 10054545 | 1.78 | 88 | null | 2022-04-21 | 2022-04-30 | CEMIPLIMAB | 02 | null | CEMIPLIMAB | 101819967 |
| 10478287 | 10054546 | 1.67 | 50 | Palliative (P) | 2017-04-02 | 2017-04-08 | BENDAMUSTINE + RITUXIMAB | 02 | Y | BENDAMUSTINE + RITUXIMAB | 101093351 |
| 10478292 | 10054547 | 1.76 | 53 | null | 2019-02-28 | 2019-03-08 | Trastuzumab 21 day maintenance | 02 | null | TRASTUZUMAB | 100855867 |
| 10478312 | 10054548 | 1.74 | 84.9 | Palliative (P) | 2019-09-20 | 2019-10-07 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 101760963 |
| 10478339 | 10054549 | 1.69 | 86.2 | 03 | 2022-01-10 | 2022-01-29 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100368632 |
| 10478353 | 10054550 | 1.76 | 62.1 | 03 | 2021-10-08 | 2021-10-29 | Avelumab | 02 | N | BENDAMUSTINE + RITUXIMAB | 100837732 |
| 10478471 | 10054551 | 1.73 | 71.5 | null | 2020-01-30 | 2021-05-04 | Capecitabine + Oxaliplatin 14day | 02 | null | CAPECITABINE + OXALIPLATIN | 101628324 |
| 10478479 | 10054552 | 1.66 | 68.2 | null | 2018-04-11 | 2018-04-13 | Avelumab | 02 | null | AVELUMAB | 101433231 |
| 10478526 | 10054553 | 1.53 | null | null | 2018-11-29 | 2018-11-29 | Avelumab | 02 | null | CEMIPLIMAB | 101715442 |
| 10478529 | 10054554 | 1.58 | 82.8 | Palliative (P) | 2019-12-12 | 2019-12-26 | Avelumab | 02 | N | AVELUMAB | 100952789 |
| 10478651 | 10054555 | 1.49 | 66.1 | 03 | 2018-02-11 | 2018-02-11 | Avelumab | 02 | N | AVELUMAB | 101285301 |
| 10478666 | 10054556 | 1.73 | 97.6 | Palliative (P) | 2020-01-17 | 2020-02-01 | CEMIPLIMAB | 02 | null | CEMIPLIMAB | 100445526 |
| 10478719 | 10054557 | 1.78 | 104 | Palliative (P) | 2018-10-23 | 2018-11-13 | Oxaliplatin + Modified de Gramont | 02 | N | FLUOROURACIL + OXALIPLATIN | 101200475 |
| 10478734 | 10054558 | 1.75 | 78.6 | null | 2020-11-02 | 2020-11-06 | Trastuzumab Subcutaneous | 02 | null | TRASTUZUMAB | 101754872 |
| 10478765 | 10054559 | 1.82 | 88.2 | null | 2020-03-12 | 2020-03-22 | CEMIPLIMAB | 02 | null | CEMIPLIMAB | 100832852 |
| 10478827 | 10054560 | null | 84.6 | null | 2016-05-20 | 2016-10-16 | Avelumab | 02 | null | VENETOCLAX | 101557125 |
| 10478838 | 10054561 | 1.6 | 46.5 | Palliative (P) | 2022-03-31 | 2022-04-04 | Avelumab | 02 | N | BENDAMUSTINE + RITUXIMAB | 100148991 |
| 10478886 | 10054562 | 1.61 | 72 | Palliative (P) | 2017-07-07 | 2017-07-13 | Venetoclax | 02 | N | VENETOCLAX | 100964971 |
| 10478910 | 10054563 | 1.68 | 97.3 | Adjuvant (A) | 2018-06-26 | 2018-07-15 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE + OXALIPLATIN | 101194287 |
| 10478951 | 10054564 | 1.49 | 107.6 | Palliative (P) | 2018-06-29 | 2018-06-29 | Avelumab | 02 | N | AVELUMAB | 101866871 |
| 10478965 | 10054565 | 1.69 | 80.7 | null | null | 2016-08-15 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101863098 |